Search Results - "BUCKINGHAM, ROBIN E."
-
1
Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ, Inhibits the Jun NH2-Terminal Kinase/Activating Protein 1 Pathway and Protects the Heart From Ischemia/Reperfusion Injury
Published in Diabetes (New York, N.Y.) (01-05-2002)“…Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ, Inhibits the Jun NH 2 -Terminal Kinase/Activating Protein 1 Pathway and Protects the Heart From…”
Get full text
Journal Article -
2
Thiazolidinedione Treatment Normalizes Insulin Resistance and Ischemic Injury in the Zucker Fatty Rat Heart
Published in Diabetes (New York, N.Y.) (01-04-2002)“…Thiazolidinedione Treatment Normalizes Insulin Resistance and Ischemic Injury in the Zucker Fatty Rat Heart Robert J. Sidell 1 , Mark A. Cole 1 , Nicholas J…”
Get full text
Journal Article -
3
Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat
Published in Peptides (New York, N.Y. : 1980) (01-09-1999)“…Two novel hypothalamic neuropeptides, orexin-A and -B, are suggested to regulate feeding. A single intracerebroventricular injection of orexin-A (23.4 nmol),…”
Get full text
Journal Article -
4
Thiazolidinediones and their fluid-related adverse effects : Facts, fiction and putative management strategies
Published in Drug safety (2007)“…Thiazolidinediones (TZDs) or glitazones are agents that are widely used for the treatment of type 2 diabetes mellitus. These drugs have a multitude of…”
Get full text
Journal Article -
5
Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes
Published in Circulation (New York, N.Y.) (24-06-2003)“…It is well known that patients with type 2 diabetes have increased risk of cardiovascular disease, but it is not known whether they have underlying…”
Get full text
Journal Article -
6
-
7
β-cell mass dynamics in Zucker diabetic fatty rats rosiglitazone prevents the rise in net cell death
Published in Diabetes (New York, N.Y.) (01-05-2001)“…The evolution of diabetes in the male leptin receptor-deficient (fa/fa) Zucker diabetic fatty (ZDF) rat is associated with disruption of normal islet…”
Get full text
Journal Article -
8
Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior
Published in Cell (20-02-1998)“…The hypothalamus plays a central role in the integrated control of feeding and energy homeostasis. We have identified two novel neuropeptides, both derived…”
Get full text
Journal Article -
9
In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone
Published in Circulation (New York, N.Y.) (20-11-2001)“…Diabetes is associated with increased risk of mortality as a consequence of acute myocardial infarction. This study determined whether rosiglitazone (ROSI)…”
Get full text
Journal Article -
10
The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats
Published in Diabetes (New York, N.Y.) (01-07-1999)“…The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. A B Walker…”
Get full text
Journal Article -
11
Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord
Published in Peptides (New York, N.Y. : 1980) (01-12-1999)“…The orexins are recently identified appetite-stimulating hypothalamic peptides. We used immunohistochemistry to map orexin-A and orexin-B immunoreactivity in…”
Get full text
Journal Article -
12
Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro
Published in Diabetes (New York, N.Y.) (01-05-1998)“…Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. A B Walker , E K…”
Get full text
Journal Article -
13
Central Exendin-4 Infusion Reduces Body Weight without Altering Plasma Leptin in ( ) Zucker Rats
Published in Obesity (Silver Spring, Md.) (01-07-2000)“…Objective: To investigate whether chronic administration of the long‐acting glucagon‐like peptide‐1 receptor agonist exendin‐4 can elicit sustained reductions…”
Get full text
Journal Article -
14
Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor?
Published in Regulatory peptides (25-09-1998)“…Food intake was measured in freely fed rats following intracerebroventricular administration of neuropeptide Y (NPY) and several of its analogues and…”
Get full text
Journal Article -
15
The haemodynamic profile of cromakalim in the cat
Published in Journal of cardiovascular pharmacology (01-11-1988)“…The haemodynamic profile of the novel antihypertensive agent, cromakalim (BRL 34915), has been studied in conscious and anaesthetised cats. Given orally (0.03…”
Get more information
Journal Article -
16
β-Cell Mass Dynamics in Zucker Diabetic Fatty Rats
Published in Diabetes (New York, N.Y.) (01-05-2001)“…β-Cell Mass Dynamics in Zucker Diabetic Fatty Rats Rosiglitazone Prevents the Rise in Net Cell Death Diane T. Finegood 1 , M. Dawn McArthur 1 , David Kojwang 1…”
Get full text
Journal Article -
17
Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat
Published in British journal of pharmacology (01-05-1989)“…1 In rat isolated thoracic aortic rings pre‐contracted with noradrenaline (10−6 m), cromakalim (3 × 10−7‐3 × 10−5 m) produced concentration‐related relaxation…”
Get full text
Journal Article -
18
Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and Zucker diabetic fatty rats and effects of rosiglitazone
Published in Brain research. Molecular brain research. (14-04-2000)“…Orexins (hypocretins) are lateral hypothalamic neuropeptides implicated in regulating feeding and the sleep–wake cycle. To study their possible relevance to…”
Get full text
Journal Article -
19
Synthesis and antihypertensive activity of 4-(cyclic amido)-2H-1-benzopyrans
Published in Journal of medicinal chemistry (01-11-1986)“…The synthesis and antihypertensive activity of a series of novel 4-(cyclic amido)-2H-1-benzopyran-3-ols, administered orally to conscious spontaneously…”
Get full text
Journal Article -
20
Differences between the Vasorelaxant Activity of Adenosine-receptor Agonists on Guinea-pig Isolated Aorta Precontracted with Noradrenaline or Phenylephrine
Published in Journal of pharmacy and pharmacology (01-10-1999)“…The relaxant effect of adenosine and 5′‐(N‐ethylcarboxamido)adenosine (NECA) against α‐adrenoceptor‐mediated contractile tone in guinea‐pig isolated aortic…”
Get full text
Journal Article